InVivo Therapeutics 2016 Investor Presentation

InVivo Therapeutics presents its pipeline for spinal cord injury treatments, including the Neuro-Spinal Scaffold for acute SCI in pivotal study and Therapeutic Trails for chronic SCI in research phase. The company reports compelling early data with 54.5% of patients regaining neurologic function and plans FDA filing in late 2017 or early 2018. Leadership includes Nobel Laureate Richard Roberts and renowned neuroscientist Robert Langer.